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An aim of systems biology is to understand complex interactions between genes, proteins and 
metabolites by integrating and modeling multiple data sources. We report an integrated-omics approach 
within XCMS Online1 that automatically superimposes raw metabolomic data onto metabolic pathways, 
and integrates it with transcriptomic and proteomic data (XCMSOnline.scripps.edu).  
Mapping downstream metabolite changes onto metabolic pathways and biological networks can 
provide considerable mechanistic insight that can be confirmed by association to multi-omic data. 
However, pathway analysis using untargeted metabolomics requires intense data curation, including 
feature filtering, statistical analysis and metabolite identification. Subjectively defined values such as 
fold change, p-value, and signal intensity cut-off are needed to identify significantly dysregulated 
metabolite features within enormous datasets. Confirming metabolite identities for pathway analysis 
typically requires additional tandem mass spectrometry (MS/MS) experiments and matching the spectra 
to standards or MS/MS spectral databases. The magnitude of these datasets makes it impractical to 
manually interpret and therefore the use of bioinformatic tools at each step is essential. Multiple analysis 
platforms are often needed to complete the entire workflow, which can take several weeks depending on 
the size of the sample cohort and the experience of the analyst.  
XCMS was originally developed as a metabolomics data processing algorithm to extract 
metabolic features out of raw MS data and perform statistical analysis. The evolution of XCMS from a 
command line tool2 to an intuitive cloud-based online platform1 facilitated its use by a broader 
community. However, the community is still in need of user-friendly tools to take metabolomic output 
and associate it with metabolic pathways to identify aberrant biological processes. To address this 
demand, we implemented automated predictive pathway analysis3 that operates directly on the entire 
metabolic feature table into the XCMS Online workflow (Fig. 1), removing the need to transfer data to 
another application, and enabling quick and efficient pathway analysis. This process involves uploading 
raw MS data to XCMS Online where the statistically significant features are identified, then using 
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Fisher’s exact test, dysregulated metabolic pathways are identified from the processed accurate mass 
data.3 If gene and protein data are available, they are uploaded and overlaid with the results of the 
metabolomic analysis. Currently there are over 7600 metabolic models available for pathway analysis 
from BioCyc v19.5 – 20.0 with contents being updated regularly. Further confirmation of dysregulated 
pathways can be performed by comparing metabolite spectra, obtained via targeted or autonomous 
MS/MS, with standard fragmentation spectra from METLIN, which contains MS/MS data on over 
14,000 molecules4. To address instances where a standard spectrum is not available, we have also 
recently added machine learning in silico fragmentation data to METLIN, generating MS/MS spectra on 
over 220,000 additional molecules. Our workflow enables (1) evaluation of biochemical relevance by 
mapping high resolution MS data directly onto pathways, (2) cross-integration of genomic and 
proteomic data and (3) metabolite identity verification via data dependent MS/MS analysis either 
separately or as part of the autonomous workflow4. 
Our multi-omic analysis tool uses embedded BioCyc5 and Uniprot6 databases to map user-
uploaded gene and protein data onto the predicted metabolic pathways (Supplementary Figure 1). 
Results can be viewed in table form or using the interactive Pathway Cloud Plot (Figure 1). 
Visualization of dysregulated pathways appear with greater overlap and statistical significance in the 
upper right-hand quadrant of the cloud plot. Graph features can be clicked to view more information on 
overlapping gene, protein and metabolite data, with links to BioCyc, KEGG, and METLIN. Important 
features can be readily identified, helping to decipher underlying biological mechanisms. Details on the 
pathway analysis and integrated omics workflow can be found in the Supplementary Methods. 
Currently, data sharing is possible between collaborators and the public and we encourage users to share 
their data in the XCMS Online community.  
To demonstrate metabolic pathway analysis and multi-omic integration, we describe a number of 
representative sample sets in the Supplementary Note, including metabolic pathway analysis using 
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progenitor cell proliferation data and a bacterial induced corrosion study (Supplementary Figure 2); 
proteomic integration with an aging study (Supplementary Figure 3); transcriptomic and proteomic 
integration using a human colon cancer study (Supplementary Figure 4 and Supplementary Table 1), 
a sulfate reducing bacteria nitrate stress-response study (Supplementary Figure 5) and a microbial 
media stress-response study (Supplementary Table 2 and Supplementary Figure 6); and a cohort of 
1,600 diabetes plasma samples (Supplementary Figure 7) which helps illustrate the scalability of the 
cloud-based XCMS Online.  
Other notable tools providing pathway analysis and multi-omic integration include Galaxy-M7, 
Open MS from KNIME8, and MetaboAnalyst9. However, many of these tools still require separate 
preprocessing of LC-MS data and are not fully integrated into a single program. Our workflow 
automatically maps metabolomic data directly onto pathways and integrates transcriptomics and 
proteomics for systems-wide interpretation in one cohesive platform. Additionally, metabolic network 
mapping is available based on the predictive activity network algorithm3 for analysis of metabolomic 
data only, with multi-omics networking in development. In the future, we will incorporate unique 
metabolic pathways and networks from other sources to provide more comprehensive biological 
resources.  
 
Data Availability 
 To assist users with the new workflow, we have provided a sample dataset entitled “Ecoli_glucose-vs-
adenosine” (Job ID#1133019) that can be found on XCMS Online under XCMS Public 
(https://xcmsonline.scripps.edu/landing_page.php?pgcontent=listPublicShares), as well as two 
instructional videos available within the XCMS Institute 
(https://xcmsonline.scripps.edu/landing_page.php?pgcontent=institute) under the Omics tab and by 
clicking Integrated Omics or Pathway Cloud Plot. 
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Figure 1. Workflow for metabolomic data and pathway analysis using XCMS Online. A Metabolite Feature 
Table of statistically significant features is generated from standard XCMS processing; these features 
automatically undergo Predictive Pathway Mapping using a specified biological model. The pathway cloud plot 
shows Dysregulated Pathways (blue circles) with increasing statistical significance on the y-axis, metabolite 
overlap on the x-axis and total number of metabolites in the pathway represented by the circle radius. The 
Multiscale Pathway Coverage table presents enriched metabolic pathways with overlapped and total metabolites, 
genes and proteins. MS/MS Data confirms dysregulated pathways by matching metabolite MS/MS spectra with 
the METLIN database. 
 
